Eleven Biotherapeutics, Inc. 4
4 · Eleven Biotherapeutics, Inc. · Filed Aug 14, 2015
Insider Transaction Report
Form 4
MCCABE JOHN J
Senior Vice President, Finance
Transactions
- Award
Common Stock
2015-08-12+10,000→ 10,000 total - Award
Stock Option (Right to Buy)
2015-08-12+20,000→ 20,000 totalExercise: $4.09Exp: 2025-08-11→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units which vest as to 33.33% of the original number of restricted stock units granted to Mr. McCabe on each of the six-month, twelve-month and eighteen-month anniversaries of the grant date.
- [F2]This option was granted on August 12, 2015 and vests over four years, with 6.25% of the shares underlying the option vesting at the end of each successive three-month period after August 1, 2015 until August 1, 2019.